Advanced Oncotherapy logo

AVO - Advanced Oncotherapy Share Price

37.5p -1.0  -2.6%

Last Trade - 11/12/19

Sector
Healthcare
Size
Small Cap
Market Cap £93.9m
Enterprise Value £111.1m
Revenue £n/a
Position in Universe 980th / 1843
Bullish
Bearish
Unlock AVO Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AVO Revenue Unlock AVO Revenue

Net Income

AVO Net Income Unlock AVO Revenue

Normalised EPS

AVO Normalised EPS Unlock AVO Revenue

PE Ratio Range

AVO PE Ratio Range Unlock AVO Revenue

Dividend Yield Range

AVO Dividend Yield Range Unlock AVO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AVO EPS Forecasts Unlock AVO Revenue
Profile Summary

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device. The Company's segments include Development of Proton Therapy-UK; Development of Proton Therapy-Switzerland; Development of Proton Therapy-USA, and Healthcare-related properties-UK. Its LIGHT system integrates a series of modular linear accelerators. This feature offers hospitals and centers to customize treatment plans based on a range of energies. The Company's Research and development/ADAM S.A. (R&D/ADAM) facility is located on the campus of European Council for Nuclear Research (CERN), Geneva and Switzerland. The Company’s verification and validation site is located in Daresbury, United Kingdom.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated September 15, 2005
Public Since August 4, 2006
No. of Shareholders: n/a
No. of Employees: 118
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 243,842,656
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AVO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AVO
Upcoming Events for AVO
Similar to AVO
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.